Clonal Hematopoiesis
8
6
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Donor CHIP and Allogeneic HSCT Outcome
Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly